Because the medication manages insulin response and blood sugar spikes, you experience fewer energy crashes
reported that circulating GIP levels increased by more than 200 pg/mL following a mixed meal test (MMT) in individuals with obesity after sleeve gastrectomy (SG), while fasting GIP levels remained largely unchanged [22]
The following groups have typically been excluded from clinical trials or would require careful specialist assessment, reflecting cautions seen across related approved medicines: A personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2): This is a theoretical concern that has led to exclusion from trials of GLP-1 receptor agonist therapies, based on animal data
Similarly, GcgR antagonists have been reported to reduce blood glucose in STZ-induced diabetic rats [52]
Locigno R, Pincemail J, Henno A, Treusch G, Castronovo V
10.3390/jpm15110518 J Pers Med